Resistant CMV infection in a transplant patient. Letermovir and withdrawal of immunosuppression

Nefrologia (Engl Ed). 2023 Sep-Oct;43(5):661-662. doi: 10.1016/j.nefroe.2023.10.002. Epub 2023 Nov 10.

Authors

María Crucio López¹, Constantino Fernández Rivera², María Calvo Rodríguez², Ángel Alonso Hernández²

Affiliations

¹ Servicio de Nefrología, Complexo Hospitalario Universitario de Ourense, Ourense, Spain. Electronic address: maria.crucio.lopez@sergas.es.
² Servicio de Nefrología, Complexo Hospitalario Universitario de A Coruña, A Coruña, Spain.

PMID: 37951775
DOI: 10.1016/j.nefroe.2023.10.002

No abstract available

Publication types

Letter

MeSH terms

Acetates
Antiviral Agents / adverse effects
Cytomegalovirus Infections* / drug therapy
Humans
Immunosuppression Therapy / adverse effects

Substances

letermovir
Antiviral Agents
Acetates